Lannett (LCI) Catches Bid Following Phentermine HCl ANDA Approval

July 20, 2011 3:40 PM EDT
Lannett (NYSE: LCI) shares have popped higher following reports the U.S. FDA has approved its Abbreviated New Drug Application (ANDA) of Phentermine HCl Capsules, 37.5 mg.

The stock is up nearly 3 percent on the session this afternoon, after being relatively flat all day.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Insiders' Blog